Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
S01AE06	TYMER	G	Gatifloxacin (sesquihydrate) - 3mg/ml	3mg/ml	Drops solution	427,342 L.L
S01AE03	CILOXAN	B	Ciprofloxacine (HCl) - 3mg/ml	3mg/ml	Drops solution	348,055 L.L
S01AE02	NAFLOX	G	Norfloxacin - 3mg/ml	3mg/ml	Drops	370,901 L.L
S01AE01	FLOXEDOL	G	Ofloxacin - 3mg/ml	3mg/ml	Gel	339,992 L.L
S01AE01	OPTIFLOX	G	Ofloxacin - 3mg/ml	3mg/ml	Drops suspension	143,791 L.L
S01AE01	FLOXIGEN	G	Ofloxacin - 3mg/ml	3mg/ml	Drops solution	358,806 L.L
S01AE01	OFLOX	B	Ofloxacin - 0.3%	0.3%	Drops solution	366,869 L.L
S01AE01	OFLOX	B	Ofloxacin - 3mg/ml	0.3%	Drops solution	366,869 L.L
S01AD09	VIRGAN	B	Ganciclovir - 1.5mg/g	1.5mg/g	Gel	804,962 L.L
S01AA26	AZYTER	G	Azithromycin (dihydrate) - 15mg/g	15mg/g	Drops solution	412,560 L.L
S01AA23	NETTACIN	B	Netilmicin - 0.3%	0.3%	Ointment	593,978 L.L
S01AA23	NETTACIN	B	Netilmicin - 0.3%	0.3%	Drops solution	681,328 L.L
S01AA13	OPTIFUCIN VISCOUS	G	Fusidic acid - 1%	1%	Drops	208,296 L.L
S01AA13	FUCITHALMIC VISCOUS	B	Fusidic acid - 10mg/g	1%	Drops	373,588 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Ointment	280,863 L.L
S01AA12	TOBRASTILL	G	Tobramycin - 0.3%	0.3%	Drops solution	258,018 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Drops	322,522 L.L
S01AA09	TETRACYCLINE EYE OINTMENT	G	Tetracycline HCl - 1%	1%	Ointment	71,672 L.L
R07AA01	SURVANTA	B	Colfosceril palmitate - 200mg/8ml	200mg/8ml	Suspension	36,957,499 L.L
R07AA	INFASURF	B	Calfactant - 105mg/3ml	35mg/ml	Injectable suspension	23,344,161 L.L
R07AA	INFASURF	B	Calfactant - 210mg/6ml	35mg/ml	Injectable suspension	40,596,749 L.L
R07AA	SURFACTANTE B RICHET	G	Pulmonary surfactant, bovine - 200mg/8ml	200mg/8ml	Suspension	26,568,472 L.L
R06AX29	LABIXTEN	B	Bilastine - 2.5mg/ml	2.5mg/ml	Solution	463,626 L.L
R06AX29	LABIXTEN	B	Bilastine - 20mg	20mg	Tablet	584,571 L.L
R06AX28	RUPATADINE BIOGARAN	G	Rupatadine - 10mg	10mg	Tablet	341,336 L.L
R06AX27	RINA	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Syrup	159,917 L.L
R06AX27	ORADUS	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	199,657 L.L
R06AX27	DESLORATADINE ARROW	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	256,674 L.L
R06AX27	DESLORATADINE ARROW	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	249,955 L.L
R06AX27	DESLOR CHAPHA	G	Desloratadine - 0.5mg/ml	0.5mg/ml	Solution	323,802 L.L